The Department of Defense is offering the Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) grant to advance critical medical capabilities. This grant is specifically purposed to fund the development of innovative, field-deployable, and shelf-stable countermeasures designed to combat severe hemorrhage. Leveraging the latest advancements in bio-artificial blood substitute technologies, the program seeks to create robust solutions for immediate application. The overarching goal of this initiative is to significantly enhance the ability to sustain the lives of both warfighters and civilian casualties in austere, pre-hospital settings where traditional medical resources are scarce or inaccessible. This strategic investment will ensure vital support in critical situations.
Opportunity ID: 333898
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HR001121S0027 |
| Funding Opportunity Title: | Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 28, 2021 |
| Last Updated Date: | Jun 08, 2021 |
| Original Closing Date for Applications: | Aug 10, 2021 See Full Announcement for details. |
| Current Closing Date for Applications: | Aug 10, 2021 See Full Announcement for details. |
| Archive Date: | Sep 09, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All responsible sources capable of satisfying the Government’s needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information. |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings. |
| Link to Additional Information: | Beta.SAM Contract Opportunities |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
HR001121S0027@darpa.mil Email:HR001121S0027@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of Amendment 1 to HR001121S0027, the Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) Broad Agency Announcement, is to provide the DARPA Standard Cost Proposal Spreadsheet. | Jun 08, 2021 | |
| May 28, 2021 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HR001121S0027 |
| Funding Opportunity Title: | Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 28, 2021 |
| Last Updated Date: | Jun 08, 2021 |
| Original Closing Date for Applications: | Aug 10, 2021 See Full Announcement for details. |
| Current Closing Date for Applications: | Aug 10, 2021 See Full Announcement for details. |
| Archive Date: | Sep 09, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All responsible sources capable of satisfying the Government’s needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information. |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings. |
| Link to Additional Information: | Beta.SAM Contract Opportunities |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
HR001121S0027@darpa.mil Email:HR001121S0027@darpa.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HR001121S0027 |
| Funding Opportunity Title: | Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 28, 2021 |
| Last Updated Date: | May 28, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 10, 2021 See Full Announcement for details. |
| Archive Date: | Sep 09, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All responsible sources capable of satisfying the Government’s needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information. |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings. |
| Link to Additional Information: | Beta.SAM Contract Opportunities |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
HR001121S0027@darpa.mil Email:HR001121S0027@darpa.mil |
Related Documents
Folder 333898 Full Announcement-HR001121S0027 -> Attachment 2 – FSHARP SOW Template.pdf
Folder 333898 Full Announcement-HR001121S0027 -> HR001121S0027.pdf
Folder 333898 Full Announcement-HR001121S0027 -> Attachment 1 – FSHARP Executive Summary Slide.pdf
Folder 333898 Revised Full Announcement-HR001121S0027-Amendment-01 -> HR001121S0027-Amendment-01.pdf
Folder 333898 Revised Full Announcement-HR001121S0027-Amendment-01 -> Attachment 3 – Cost Proposal Spreadsheet.pdf
Packages
| Agency Contact Information: | BAA Coordinator HR001121S0027@darpa.mil Email: HR001121S0027@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00267453 | Jun 08, 2021 | Aug 10, 2021 | View |
Package 1
Mandatory forms
333898 RR_SF424_3_0-3.0.pdf
333898 AttachmentForm_1_2-1.2.pdf
333898 RR_Budget10_1_4-1.4.pdf
333898 RR_KeyPersonExpanded_3_0-3.0.pdf
333898 RR_PersonalData_1_2-1.2.pdf
Optional forms
333898 SFLLL_2_0-2.0.pdf
333898 RR_SubawardBudget10_30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
